GR3032772T3 - (r)-(z)-1-azabicyclo 2.2.1]heptan-3-one,o- 3-(3-methoxyphenyl)-2-propynyl]oxime maleate as a pharmaceutical agent - Google Patents

(r)-(z)-1-azabicyclo 2.2.1]heptan-3-one,o- 3-(3-methoxyphenyl)-2-propynyl]oxime maleate as a pharmaceutical agent

Info

Publication number
GR3032772T3
GR3032772T3 GR20000400474T GR20000400474T GR3032772T3 GR 3032772 T3 GR3032772 T3 GR 3032772T3 GR 20000400474 T GR20000400474 T GR 20000400474T GR 20000400474 T GR20000400474 T GR 20000400474T GR 3032772 T3 GR3032772 T3 GR 3032772T3
Authority
GR
Greece
Prior art keywords
heptan
azabicyclo
propynyl
methoxyphenyl
pharmaceutical agent
Prior art date
Application number
GR20000400474T
Other languages
English (en)
Inventor
Howard Yoshihisa Ando
Stephen Douglas Barrett
Juan Carlos Jaen
Steven Edward Rose
Haile Tecle
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of GR3032772T3 publication Critical patent/GR3032772T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR20000400474T 1995-06-07 2000-02-28 (r)-(z)-1-azabicyclo 2.2.1]heptan-3-one,o- 3-(3-methoxyphenyl)-2-propynyl]oxime maleate as a pharmaceutical agent GR3032772T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/474,622 US5534522A (en) 1995-06-07 1995-06-07 (R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent
PCT/US1996/006814 WO1996040687A1 (en) 1995-06-07 1996-05-13 (r)-(z)-1-azabicyclo[2.2.1]heptan-3-one,o-[3-(3-methoxyphenyl)-2-propynyl]oxime maleate as a pharmaceutical agent

Publications (1)

Publication Number Publication Date
GR3032772T3 true GR3032772T3 (en) 2000-06-30

Family

ID=23884337

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000400474T GR3032772T3 (en) 1995-06-07 2000-02-28 (r)-(z)-1-azabicyclo 2.2.1]heptan-3-one,o- 3-(3-methoxyphenyl)-2-propynyl]oxime maleate as a pharmaceutical agent

Country Status (25)

Country Link
US (1) US5534522A (el)
EP (1) EP0839148B1 (el)
JP (1) JPH11506723A (el)
KR (1) KR100383031B1 (el)
CN (1) CN1063181C (el)
AT (1) ATE187967T1 (el)
BG (1) BG63571B1 (el)
CA (1) CA2219753A1 (el)
CZ (1) CZ286528B6 (el)
DE (1) DE69605800T2 (el)
DK (1) DK0839148T3 (el)
EA (1) EA000381B1 (el)
EE (1) EE03971B1 (el)
ES (1) ES2142586T3 (el)
GE (1) GEP19991874B (el)
GR (1) GR3032772T3 (el)
HK (1) HK1018055A1 (el)
HU (1) HUP9802499A3 (el)
NO (1) NO308901B1 (el)
NZ (1) NZ307946A (el)
PL (1) PL323796A1 (el)
SK (1) SK282824B6 (el)
UA (1) UA46032C2 (el)
WO (1) WO1996040687A1 (el)
ZA (1) ZA964764B (el)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
JP4933259B2 (ja) * 2003-10-02 2012-05-16 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ピロール置換インドリノン化合物の塩および多形
US7741358B2 (en) * 2005-04-14 2010-06-22 N.V. Organon Crystal form of asenapine maleate
MX2007015511A (es) * 2005-06-07 2008-03-06 Univ Ramot Sales novedosas de farmacos sicotropicos conjugados y procesos para prepararlas.
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
AU2007249435A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2051735B1 (en) 2006-07-17 2012-08-29 Ramot, at Tel Aviv University Ltd. Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use treating pain and other cns disorders
KR20090064418A (ko) 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2009101616A1 (en) 2008-02-11 2009-08-20 Ramot At Tel Aviv University Ltd. Novel conjugates for treating neurodegenerative diseases and disorders
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AU2010329440A1 (en) 2009-12-09 2012-08-09 Bar-Ilan University Methods of improving cognitive functions
AU2011219529A1 (en) 2010-02-24 2012-08-30 Bar-Ilan University Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same
WO2012038963A1 (en) 2010-09-22 2012-03-29 Ramot At Tel-Aviv University Ltd. An acid addition salt of a nortriptyline-gaba conjugate and a process of preparing same
JP5997931B2 (ja) * 2011-05-25 2016-09-28 石原産業株式会社 農園芸用殺菌剤組成物及び植物病害の防除方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306718A (en) * 1990-03-06 1994-04-26 Warner-Lambert Company Oxime and amine substituted azabicyclo and azocyclo muscarinic agonists and methods of treatment
US5346911A (en) * 1990-03-06 1994-09-13 Warner-Lambert Company Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment

Also Published As

Publication number Publication date
EP0839148A1 (en) 1998-05-06
US5534522A (en) 1996-07-09
EA000381B1 (ru) 1999-06-24
DK0839148T3 (da) 2000-05-22
NO975704D0 (no) 1997-12-05
PL323796A1 (en) 1998-04-27
NO975704L (no) 1998-01-30
BG102078A (en) 1998-11-30
UA46032C2 (uk) 2002-05-15
AU5744996A (en) 1996-12-30
KR100383031B1 (ko) 2003-10-17
WO1996040687A1 (en) 1996-12-19
CZ286528B6 (cs) 2000-05-17
NZ307946A (en) 2001-03-30
EP0839148B1 (en) 1999-12-22
SK282824B6 (sk) 2002-12-03
BG63571B1 (bg) 2002-05-31
HUP9802499A2 (hu) 1999-04-28
JPH11506723A (ja) 1999-06-15
AU697954B2 (en) 1998-10-22
CA2219753A1 (en) 1996-12-19
ZA964764B (en) 1997-01-08
ATE187967T1 (de) 2000-01-15
CN1063181C (zh) 2001-03-14
EA199800007A1 (ru) 1998-06-25
GEP19991874B (en) 1999-12-06
CN1186493A (zh) 1998-07-01
KR19990022572A (ko) 1999-03-25
SK164497A3 (en) 1998-06-03
ES2142586T3 (es) 2000-04-16
DE69605800D1 (de) 2000-01-27
HK1018055A1 (en) 1999-12-10
EE9700316A (et) 1998-06-15
CZ381797A3 (cs) 1998-05-13
EE03971B1 (et) 2003-02-17
HUP9802499A3 (en) 1999-06-28
DE69605800T2 (de) 2000-11-16
NO308901B1 (no) 2000-11-13

Similar Documents

Publication Publication Date Title
GR3032772T3 (en) (r)-(z)-1-azabicyclo 2.2.1]heptan-3-one,o- 3-(3-methoxyphenyl)-2-propynyl]oxime maleate as a pharmaceutical agent
HRP960312B1 (en) NOVEL PROCESS FOR THE PRODUCTION OF AMORPHOUS /R-(R*, R*)/-2-(4-FLUOROPHENYL)-"beta", "delta"-DIHYDROXY-5-PHENYL-4-/(PHENYLAMINO)CARBONYL/-1H-PYRROLE -1-HEPTANOIC ACID CALCIUM SALT (2 : 1)
CA2107432A1 (en) Quaternary Basic Amides, Method of Preparing Them and Pharmaceutical Compositions in Which They Are Present
CA2356300A1 (en) 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
AU633635B2 (en) Process for preparing bituminous compositions
CA2101648A1 (en) Polysaccharide-protein conjugates
CA2243542A1 (en) Resolution of threo-methylphenidate
CA2283292A1 (en) Hydrolytically stable resins for use in anion-exchange chromatography
CA2155323A1 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
CA2268399A1 (en) Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
MX9708337A (es) Maleato (r)-(z)-1-azabiciclo [2.2.1]heptan-3-one,0-[3-(3-metoxifenil)-2-propinil]-oxime como un agente farmaceutico.
HU900255D0 (en) Process for preparation of 3-phenyl-5,6-dilhydrobenz (c)-acridine-carboxylic-acids and carboxylic-acid derivatives and for manufacturing of pharmaceutical composition containing these compounds as active ingredient
CA2181566A1 (en) Compositions and Methods Using Unbound MPL Receptor for Stimulating Platelet Production
NO175565C (no) Fremgangsmåte for fremstilling av et parenteralt anvendbart, farmasöytisk preparat inneholdende et bis-indolalkaloid
MY115734A (en) Resolution of 1-azabicyclo (2.2.2.) octon -3-amine, 2-(diphenylmethyl)-n- [[2-methoxy-5-(1-mehtylethyl) phenyl]methyl]
HUP0201301A2 (en) Polymorphs of a crystalline azabicyclo(2,2,2)octan-3-amine citrate and their pharmaceutical compositions and process for preparation of the compounds
SI0839148T1 (en) (r)-(z)-1-azabicyclo 2.2.1)heptan-3-one,o- 3-(3-methoxyphenyl)-2-propynyl)oxime maleate as a pharmaceutical agent
CA2267947A1 (en) Preparation of 3-fluoro oxindole derivatives
AU6496490A (en) Zak's railways click clack sound eliminator & softener
AU3281397A (en) Process for the preparation of organic salts of n'n-diacetylcystine
GB8921463D0 (en) 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds
MX9701865A (es) Compuestos de dimetil-(3-aril-but-3-enil)-amino como ingredientes activos farmaceuticos.
AU1442099A (en) Process for the preparation of substituted 8-azabicyclo{3.2.1}octanes
EP0757040A4 (en) ADAMANTANE DERIVATIVE, PROCESS FOR PRODUCTION AND USE OF SAID DERIVATIVE
AU7746691A (en) Substituted azacyclic compounds, process for their preparation and their use as analgesics

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees